para-Ethoxyamphetamine
Tools
Actions
General
Print/export
In other projects
Appearance
From Wikipedia, the free encyclopedia
(Redirected from 4-ethoxyamphetamine)
Chemical compound
Pharmaceutical compound
| Clinical data | |
|---|---|
| Other names | 4-Ethoxyamphetamine; 4-EA; 4-ETA; 4-EtO-A; PEtOA |
| Drug class | Psychoactive drug; Stimulant; Monoamine releasing agent; Monoamine oxidase inhibitor |
| Legal status | |
| Legal status | |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider |
|
| UNII | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C11H17NO |
| Molar mass | 179.263 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| | |
para-Ethoxyamphetamine (PEtOA), also known as 4-ethoxyamphetamine (4-EA, 4-ETA, or 4-EtO-A), is a psychoactive drug of the phenethylamine and amphetamine families which is closely related to para-methoxyamphetamine (PMA). It has similar effects to PMA in animal studies, although with slightly weaker stimulant effects.[1][2][3] Like PMA, it has prominent MAOI activity,[4] and is likely to have similar dangers associated with its use.
See also
[edit]References
[edit]- ↑ Martin-Iverson MT, Yamada N, By AW, Lodge BA (December 1991). ""Designer" amphetamines: effects on behavior and monoamines with or without reserpine and/or alpha-methyl-para-tyrosine pretreatment". Journal of Psychiatry & Neuroscience. 16 (5): 253–61. PMC 1188362. PMID 1686728.
- ↑ Corrigall WA, Robertson JM, Coen KM, Lodge BA (January 1992). "The reinforcing and discriminative stimulus properties of para-ethoxy- and para-methoxyamphetamine". Pharmacology Biochemistry and Behavior. 41 (1): 165–9. CiteSeerX 10.1.1.670.6929. doi:10.1016/0091-3057(92)90077-S. PMID 1539067. S2CID 30080516.
- ↑ Hegadoren KM, Greenshaw AJ, Baker GB, Martin-Iverson MT, Lodge B, Soin S (January 1994). "4-Ethoxyamphetamine: effects on intracranial self-stimulation and in vitro uptake and release of 3H-dopamine and 3H-serotonin in the brains of rats". Journal of Psychiatry & Neuroscience. 19 (1): 57–62. PMC 1188563. PMID 8148367.
- ↑ Martin-Iverson MT, Lodge BA (December 1991). "Effects of chronic treatment of rats with "designer" amphetamines on brain regional monoamines". Canadian Journal of Physiology and Pharmacology. 69 (12): 1825–32. doi:10.1139/y91-270. PMID 1802356.
External links
[edit]| Non-specific |
| ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Phenethylamines (dopamine, epinephrine, norepinephrine) |
| ||||||||||
| Tryptamines (serotonin, melatonin) |
| ||||||||||
| Histamine |
| ||||||||||
| Phenethylamines |
| ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Amphetamines |
| ||||||||||||||||
| Phentermines |
| ||||||||||||||||
| Cathinones |
| ||||||||||||||||
| Phenylisobutylamines (and further-extended) | |||||||||||||||||
| Catecholamines (and close relatives) |
| ||||||||||||||||
| Cyclized phenethylamines |
| ||||||||||||||||
| Related compounds |
| ||||||||||||||||
Hidden categories:
- Articles with short description
- Short description matches Wikidata
- Short description is different from Wikidata
- Drugs with non-standard legal status
- Infobox drug articles with non-default infobox title
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Drugs missing an ATC code
- Drugboxes which contain changes to verified fields